Steven Reichling - Apr 26, 2022 Form 4 Insider Report for Accelerate Diagnostics, Inc (AXDX)

Role: Chief Financial Officer
Signature: /s/ Steve Reichling
Stock symbol: AXDX
Transactions as of: Apr 26, 2022
Transactions value $: -$29,317
Form type: 4
Date filed: 4/28/2022, 05:58 PM
Previous filing: Apr 6, 2022
Next filing: Aug 22, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AXDX	Common Stock	Options Exercise	$0	+57.7K	+166.52%	$0.00	92.4K	Apr 26, 2022	Direct	F1
transaction	AXDX	Common Stock	Sale	-$29.3K	-29.9K	-32.37%	$0.98	62.5K	Apr 28, 2022	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AXDX	Employee Restricted Stock Units	Options Exercise	$0	-57.7K	-100%	$0.00^*	0	Apr 26, 2022	Common Stock	57.7K		Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. On March 28, 2022, the reporting person was granted a total of 57,736 restricted stock units, which vested April 26, 2022.
F2	The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.